Sacral Neuromodulation in Patients With Double Incontinence
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity Hospital Ostrava
About this trial
This is a prospective study evaluating the effect of a treatment method of sacral neuromodulation (SNM), the use of which is approved and recommended for the treatment of both faecal incontinence (FI) and urinary incontinence (UI). A new aspect of the study is monitoring the effect of SNM in patients with both types of incontinence (faecal and urinary) occurring simultaneously. The study will use diagnostic methods and procedures that are part of the usual examination algorithm. The study will not impose any burden on patients beyond the scope of routine examination and treatment procedures.
Eligibility criteria
Qualifiers
Adult women over 18 years of age
Consent to participate in the study
Willingness to undergo examination, treatment and follow-up according to the protocol
Grade III fecal incontinence (patient is unable to consciously hold in wind, loose or hard stools)
Disqualifiers
Rapidly progressing neurological diseases
Known severe congenital malformations of the anorectum and/or lower urinary tract
Presence of a foreign body in the urinary tract - urolithiasis, urinary catheter, ureteral stent
Pregnancy, lactation
Trial design
Treatments tested in this trial
- Sacral neurostimulation
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov